Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea

被引:17
|
作者
Cho, Minho
Park, Jong Suk
Nam, Jisun
Kim, Chul Sik [2 ]
Nam, Jae Hyun
Kim, Hai Jin
Ahn, Chul Woo [1 ]
Cha, Bong Soo
Lim, Sung Kil
Kim, Kyung Rae
Lee, Hyun Chul
Huh, Kap Bum [3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 135720, South Korea
[2] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea
[3] 21 Century Diabet & Vasc Res Inst, Seoul, South Korea
关键词
Obesity; Insulin Resistance; Diabetes Mellitus Type 2; Atherosclerosis;
D O I
10.3346/jkms.2008.23.5.781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to investigate the relationship between obesity, insulin resistance and atherosclerosis in type 2 diabetes mellitus (T2DM) patients. Total 530 patients with T2DM were included. To evaluate the severity of atherosclerosis, we measured the coronary artery calcification (CAC) score, intima-media thickness (IMT) of the common carotid artery, and the ankle-brachial pressure index (ABPI). Subjects were classified according to body mass index (BMI), a marker of general obesity, and waist- to-hip ratio (WHIR), a marker of regional obesity. The insulin sensitivity index (ISI) was measured by the short insulin tolerance test. All subjects were classified into four groups, according to BMI: the under-weight group, the normal-weight (NW) group, the over-weight (OW) group, and the obese (OB) group. WHR and systolic blood pressure, triglycerides (TG), HDL- cholesterol (HDL-C), free fatty acids (FFA), fibrinogen, and fasting c-peptide levels were significantly different between BMI groups. TG, HDL-C, FFA, fibrinogen and ISI were significantly different between patients with and without abdominal obesity. In the OW group as well as in the NW group, carotid IMT, ABPI and CAC score were significantly different between patients with and without abdominal obesity. This study indicates that abdominal obesity was associated with atherosclerosis in T2DM patients.
引用
收藏
页码:781 / 788
页数:8
相关论文
共 50 条
  • [31] Life Expectancy of Individuals with Type 2 Diabetes Mellitus (T2DM) in the United States
    Kianmehr, Hamed
    Yang, Shuang
    Fonseca, Vivian
    Shi, Lizheng
    Brown, Joshua D.
    Guo, Yi
    Shao, Hui
    DIABETES, 2020, 69
  • [32] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [33] The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
    Stedman, Mike
    Rea, Rustam
    Duff, Christopher J.
    Livingston, Mark
    McLoughlin, Katie
    Wong, Louise
    Brown, Stephen
    Grady, Katherine
    Gadsby, Roger
    Gibson, John M.
    Paisley, Angela
    Fryer, Anthony A.
    Heald, Adrian H.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (02)
  • [34] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [35] Glycaemic control and pregnancy outcomes in women with Type 2 diabetes mellitus (T2DM)
    Pang, W. H.
    Tan, Z.
    Todd, D.
    Halliday, M.
    Gill, F.
    Rhoads, M.
    Sathiskumar, P.
    Gallagher, A.
    de Chazal, R.
    Lawrence, I. G.
    DIABETIC MEDICINE, 2008, 25
  • [36] Interrogating the Signaling Mechanisms of GPR119: a Novel Target for Type 2 Diabetes Mellitus (T2DM) and Obesity
    Adhikari, Pramisha
    Sturchler, Emmanuel
    Mcdonald, Patricia
    DIABETES, 2016, 65 : A448 - A448
  • [37] Regional effects of type 2 diabetes mellitus (T2DM) on grey matter atrophy
    Moran, C.
    Phan, T. G.
    Beare, R.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 : 34 - 34
  • [38] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [39] The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
    Wang, Mengjiao
    Chen, Min
    Guo, Rui
    Ding, Yangyang
    Zhang, Haihui
    He, Yuanqing
    Trends in Food Science and Technology, 2022, 129 : 397 - 407
  • [40] The Impact of Obesity on Incidence of Type 2 Diabetes Mellitus (T2DM) among Women with Polycystic Ovary Syndrome (PCOS)
    Kakoly, Nadira Sultana
    Earnest, Arul
    Teede, Helena
    Moran, Lisa
    Loxton, Deborah
    Joham, Anju E.
    DIABETES, 2018, 67